China Heihe-Russia Kanikurgan Highway Port Passenger Transport was officially opened. On December 10th, with the first passenger completing the exit formalities, China Heihe Highway Port-Russia Kanikurgan Highway Port Passenger Transport was officially opened. Passengers take buses from Heihe International Highway Passenger Station in China and Amoula Suo International Bus Station in Blagoveshchensk, Russia, respectively, and cross the Sino-Russian cross-border highway bridge, with four buses entering and leaving each country every day. After the official opening of passenger transportation at Heihe Highway Port, the functions of Sino-Russian highway ports have been further improved, providing a more convenient channel for cross-border communication. (Xinhua News Agency)A residential land in Yiwu, Zhejiang Province was sold in 53 rounds of bidding, with a premium rate of 23.42%. On December 10th, Yiwu City, Zhejiang Province welcomed another residential land for sale, which was named as Qintang Hub Station Plot I, located in Choucheng Street, with a land area of 63,440.94 square meters and a plot ratio of 1.01 million yuan, equivalent to the initial price of 1,152.72 million yuan.Zhejiang provincial enterprise asset disposal platform signed the first batch of contracts and officially started the entrusted receipt and disposal of more than 370 assets. According to Zhejiang Daily, on December 6, the provincial enterprise asset disposal platform signed strategic cooperation agreements with the first batch of four provincial enterprises, including Hangzhou Iron and Steel Group, Provincial Agricultural Development Group, Zhejiang University Holding Group and Provincial Natural Resources Group, and officially started the entrusted receipt and disposal of more than 370 assets, including equity, creditor's rights, land and real estate.
Reserve Bank of Australia: It will take some time for inflation to continue to reach its target. The job market is still tight. The economic situation has affected the family's discretionary expenditure. The gap between total demand and supply continues to narrow, and output growth is weak.Reserve Bank of Australia: The issue of interest rate cuts was not explicitly discussed. Reserve Bank of Australia President Brock said that interest rate cuts were not explicitly considered, and interest rate hikes were not discussed. Considering whether the current policy stance is appropriate. The Committee believes that the economic situation is basically in line with the forecast.The interest rates of 10-year treasury bonds and CDB active bonds all went down by about 5bp, while those of 24 interest-bearing treasury bonds went down by 4.9bp to 1.856%, and those of 24 CDB dropped by 5.25bp to 1.9175%.
Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.Morgan Stanley issued a technical opinion report that it is believed that the share price of CITIC Securities will rise in the next 30 days. The bank believes that the above scenario will happen 70% to 80% of the time. The bank pointed out that the upward trend is mainly due to the supportive policy tone before the domestic economic work conference, which may raise market sentiment, which should promote the average daily trading volume to rebound and increase market leverage. The bank believes that CITIC Securities is a high-quality and widely recognized brokerage firm, and will have good conditions to consolidate its market share when capital market activities increase. Morgan Stanley gave CITIC Securities a rating of "keeping pace with the market" and a target price of HK$ 21.2.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13